Barry Singer, MD, explains why setting realistic expectations about MS treatments is key to managing the disease effectively.

Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...

The patient support program Cycle Vita will be available for people with MS taking Bafiertam (monomethyl fumarate) starting ...

Frances Flemming gave her brain to science after choosing voluntary assisted dying. Donations such as hers are crucial to ...

At one point during her health journey, Chandler resident Erin Kienlen thought she had amyotrophic lateral sclerosis, or ALS.

The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...

According to the National MS Society, nearly one million people are living with MS in the U.S. The annual Walk MS event has been going on for decades in Savannah, and people who have been coming out ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...

Roche said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy ...

Roche’s phase III MUSETTE trial of Ocrevus high dose in people with relapsing multiple sclerosis fails to meet primary endpoint: Basel Friday, April 4, 2025, 11:00 Hrs [IST] Roc ...

Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from ...

In today’s health headlines, March is Multiple Sclerosis Awareness Month. Nearly 400,000 people in the U.S. live with the condition.